Nasal spray addiction: what the science says about rebound congestion

What's this video probably claiming?

Based on the caption and hashtags, @nathalietadic is almost certainly venting about being stuck in a cycle of nasal spray dependency, specifically with Otrivin (xylometazoline), a common over-the-counter decongestant spray sold across Scandinavia and Europe. The Swedish hashtag "nässpraysberoende" translates directly to "nasal spray addiction," which tells you exactly where this is going. She's probably describing the classic trap: you use the spray, congestion clears, then comes back worse than before, so you use it again. The video appears to be asking her audience for tips on how to stop. This is an incredibly common experience. Estimates suggest that rhinitis medicamentosa, the clinical term for rebound congestion caused by topical decongestants, affects a significant but poorly quantified proportion of regular nasal decongestant users, with some ENT literature suggesting up to 9.4% of the general population uses nasal decongestants regularly enough to be at risk.

What does the science actually show?

Rhinitis medicamentosa (RM) is a real, well-documented condition caused by prolonged use of topical alpha-adrenergic agonists like xylometazoline and oxymetazoline. The mechanism involves downregulation of alpha-adrenergic receptors and rebound vasodilation when the drug wears off, creating congestion worse than the original symptom. Baroody et al. (2011, Otolaryngology Head and Neck Surgery) noted that most ENT guidelines recommend limiting these sprays to three to five days of continuous use to avoid RM. The evidence on exactly how quickly dependency develops is actually thinner than you'd expect. A frequently cited threshold of "3 days" appears in package inserts but the clinical trial evidence supporting a specific cutoff is limited. Graf (1996, Rhinology) documented structural changes in nasal mucosa with extended use. Withdrawal approaches range from cold turkey to gradual tapering, with some clinicians using intranasal corticosteroids like fluticasone to ease the transition. A small but useful randomized controlled trial by Vaidyanathan et al. (2010, JAMA) found intranasal corticosteroid use during decongestant withdrawal significantly improved outcomes compared to cold turkey alone.

Where does the social media noise diverge from clinical reality?

The comments section of videos like this one tends to produce two categories of advice, both somewhat problematic. The first is "just stop cold turkey," which ignores that withdrawal congestion can be genuinely miserable for one to two weeks and may cause people to relapse immediately. The second is anecdotal remedies with no evidence base, like saline rinses alone being sufficient to break the cycle (they help, but they're not a standalone solution for established RM). What almost never gets mentioned on TikTok is that the most evidence-backed approach involves a clinician prescribing a short course of intranasal corticosteroids to manage the rebound phase. Nobody on social media is telling you to see a doctor for what feels like a minor problem. Also worth noting: this video is categorized under peptides on FormBlends' platform, which is almost certainly a miscategorization. Nothing in the caption or hashtags suggests peptide content. Compounds like BPC-157 or GHK-Cu have zero established clinical evidence for treating rhinitis medicamentosa, and suggesting otherwise would be irresponsible.

What should you actually know?

If you recognize yourself in this video, a few things are worth knowing before you take advice from a comment section. First, rhinitis medicamentosa is a physiological dependency, not a character flaw. The packaging-recommended limit of three to five days exists for a reason, and it's easy to blow past it when you're congested and the spray provides immediate relief. Second, cold turkey works for many people but the rebound congestion in the first three to seven days is real and rough. Third, intranasal corticosteroids (available by prescription in most markets) have the best evidence for easing withdrawal. Fourth, if your underlying congestion is allergic or structural, treating that root cause is what prevents you from ending up back on the spray six months later. Finally, this is a case where a five-minute telehealth consultation is genuinely worth more than a hundred TikTok comments. The condition resolves with proper management, but you need an actual plan, not a crowdsourced one.